LAVA Therapeutics (LVTX) Institutional Ownership $1.78 0.00 (0.00%) (As of 11:24 AM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for LAVA Therapeutics (NASDAQ:LVTX)Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$287.13KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$385.18K Get LVTX Insider Trade Alerts Want to know when executives and insiders are buying or selling LAVA Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LVTX Institutional Buying and Selling by Quarter Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] LAVA Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/20/2024 Virtu Financial LLC19,103$32K0.0%N/A0.075% 11/15/2024 Sphera Funds Management LTD.146,457$243K0.0%-60.2%0.000% 11/14/2024 Walleye Capital LLC14,762$25K0.0%-42.5%0.000% 10/8/2024 Pathway Financial Advisors LLC102,500$170K0.0%+70.8%0.404% 8/12/2024 XTX Topco Ltd30,807$55K0.0%N/A0.122% 7/24/2024 Pathway Financial Advisors LLC60,000$108K0.0%+328.6%0.000% Get the Latest News and Ratings for LVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/10/2024 Pathway Financial Advisors LLC14,000$47K0.0%N/A0.000% 5/12/2023 Bruce & Co. Inc.671,874$1.12M0.3%+571.9%2.650% 2/10/2023 PNC Financial Services Group Inc.50,000$175K0.0%N/A0.197% 2/1/2023 Bank of Montreal Can89,600$530K0.0%N/A0.353% 11/14/2022 UBS Oconnor LLC75,000$343K0.0%N/A0.296% 10/28/2022 Silverarc Capital Management LLC610,809$2.79M0.9%N/A2.409% 8/16/2022 DAFNA Capital Management LLC128,335$379K0.1%-7.9%0.506% 8/15/2022 Nantahala Capital Management LLC322,980$953K0.0%-3.3%1.274% 2/14/2022 Point72 Asset Management L.P.119,152$655K0.0%-3.8%0.470% 11/15/2021 Point72 Asset Management L.P.123,911$734K0.0%N/A0.489% 11/15/2021 AXA S.A.229,121$1.36M0.0%+3.8%0.904% 11/12/2021 Falcon Edge Capital LP140,229$830K0.1%-3.2%0.553% 8/17/2021 Woodline Partners LP86,904$946K0.0%-23.3%0.343% 8/17/2021 Millennium Management LLC138,831$1.51M0.0%-38.6%0.548% 8/16/2021 Redmile Group LLC2,816,196$30.64M0.5%-0.3%11.108% 8/13/2021 Geode Capital Management LLC12,997$141K0.0%N/A0.051% 8/11/2021 Bank of New York Mellon Corp25,288$275K0.0%-26.3%0.100% 8/10/2021 Nicholas Investment Partners LP781,867$8.51M0.5%-4.0%3.084% 8/2/2021 New York State Common Retirement Fund19,136$208K0.0%-26.3%0.075% 5/27/2021 Davidson Kempner Capital Management LP2,000$30K0.0%N/A0.008% 5/18/2021 Millennium Management LLC226,205$3.44M0.0%N/A0.892% 5/18/2021 Point72 Asset Management L.P.5,561$84K0.0%N/A0.022% 5/18/2021 Tudor Investment Corp Et Al19,614$298K0.0%N/A0.077% 5/18/2021 Redmile Group LLC2,824,409$42.90M0.6%N/A11.141% 5/18/2021 Davidson Kempner Capital Management LP2,000$30K0.0%N/A0.008% 5/18/2021 Citadel Advisors LLC60,442$918K0.0%N/A0.238% 5/18/2021 Falcon Edge Capital LP150,454$2.29M0.1%N/A0.593% 5/17/2021 Point72 Hong Kong Ltd9,355$142K0.0%N/A0.037% 5/17/2021 Woodline Partners LP113,242$1.72M0.0%N/A0.447% 5/17/2021 Caas Capital Management LP30,000$456K0.0%N/A0.118% 5/17/2021Pinz Capital Management LP25,900$393K0.1%N/A0.102% 5/17/2021 Sphera Funds Management LTD.213,894$3.25M0.2%N/A0.844% 5/17/2021 Novo Holdings A S3,327,312$50.54M2.1%N/A13.124% 5/14/2021 Nantahala Capital Management LLC381,227$5.79M0.2%N/A1.504% Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown.5/14/2021 Nicholas Investment Partners LP814,840$12.38M0.9%N/A3.214% 5/14/2021 Monashee Investment Management LLC265,000$3.02M0.5%N/A1.045% 5/13/2021 Bank of New York Mellon Corp34,319$521K0.0%N/A0.135% 5/12/2021 Pura Vida Investments LLC54,000$820K0.0%N/A0.213% (Data available from 1/1/2016 forward) LVTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LVTX shares? During the previous two years, the following institutional investors and hedge funds held shares of LAVA Therapeutics shares: Bruce & Co. Inc. ($1.12M), Bank of Montreal Can ($530K), Sphera Funds Management LTD. ($243K), PNC Financial Services Group Inc. ($175K), Pathway Financial Advisors LLC ($170K), XTX Topco Ltd ($55K), and Virtu Financial LLC ($32K).Learn more on LVTX's institutional investors. Which institutional investors have been buying LAVA Therapeutics stock? The following institutional investors have purchased LAVA Therapeutics stock in the last 24 months: Bruce & Co. Inc. ($571.87K), Pathway Financial Advisors LLC ($102.50K), Bank of Montreal Can ($89.60K), PNC Financial Services Group Inc. ($50K), XTX Topco Ltd ($30.81K), and Virtu Financial LLC ($19.10K). How much institutional buying is happening at LAVA Therapeutics? Institutional investors have bought a total of 863,884 shares in the last 24 months. This purchase volume represents approximately $1.73M in transactions. Which LAVA Therapeutics major shareholders have been selling company stock? The following institutional investors have sold LAVA Therapeutics stock in the last 24 months: Sphera Funds Management LTD. ($221.13K), and Walleye Capital LLC ($10.91K). How much institutional selling is happening at LAVA Therapeutics? Institutional investors have sold a total of 232,038 shares in the last 24 months. This volume of shares sold represents approximately $385.18K in transactions. Related Companies Sagimet Biosciences Major Shareholders Cassava Sciences Major Shareholders Actuate Therapeutics Major Shareholders Organigram Major Shareholders Atossa Therapeutics Major Shareholders Puma Biotechnology Major Shareholders Gossamer Bio Major Shareholders Coherus BioSciences Major Shareholders FitLife Brands Major Shareholders Elutia Major Shareholders This page (NASDAQ:LVTX) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LAVA Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share LAVA Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
